Status:
UNKNOWN
IMAGE-HF: Project IIa Canadian CArdiomyopathy Registry for Device Therapy
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Heart Failure
Eligibility:
All Genders
Brief Summary
Delayed enhanced MRI in patients (of either ischemic or non-ischemic cause) being referred for primary prevention ICD
Detailed Description
Device therapy using defibrillators and cardiac resynchronization therapy (CRT) is an important advance in the care of patients with acquired heart disease and heart failure. In specific groups these ...
Eligibility Criteria
Inclusion
- .Any patient accepted for primary prevention ICD (+/-) CRT)
Exclusion
- Known contra-indications to MRI.
- Recent myocardial infarction or revascularization procedure within the past 3 months.
- GFR (glomerular filtration rate) ≤ 30 ml. / min/ m2.
Key Trial Info
Start Date :
October 11 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
502 Patients enrolled
Trial Details
Trial ID
NCT04908306
Start Date
October 11 2011
End Date
August 1 2023
Last Update
February 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.